Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia (2021)
Attributed to:
UKRMP Hub: The Engineered Cell Environment.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/13993003.00455-2020
PubMed Identifier: 33795320
Publication URI: http://europepmc.org/abstract/MED/33795320
Type: Journal Article/Review
Parent Publication: European Respiratory Journal
Issue: 4
ISSN: 0903-1936